GlassScriptPhysician profile
Lauren J Phillips
NPI 1598900516
$2,549.35
in general payments reported to CMS, 2019-2025
19 companies · $836 in 2025
The $836 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $116 · 2023: $764 · 2024: $675 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,275.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.10 | 2021-2025 | |
| Dexcom, INC. | $317.18 | 2023-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $309.93 | 2023-2025 | |
| Novo Nordisk INC | $252.45 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Sequel Med Tech, LLC | $240.95 | 2025 | Twiist |
| Amgen INC. | $160.99 | 2023-2025 | Prolia, Evenity |
| Tandem Diabetes Care, INC. | $160.82 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Alexion Pharmaceuticals, INC. | $128.73 | 2024 | Ultomiris |
| Antares Pharma, INC. | $101.91 | 2024-2025 | Xyosted |
| Abbott Laboratories | $94.07 | 2022-2025 | Freestyle Libre 3, Mitraclip, Freestyle Libre 2 |
| Inspire Medical Systems, INC. | $92.85 | 2023 | Inspire |
| Beta Bionics, INC. | $72.81 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Lilly USA, LLC | $66.37 | 2024-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $64.33 | 2023 | Andexxa |
| Corcept Therapeutics | $57.60 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $29.50 | 2025 | Yorvipath |
| Alvogen INC | $18.83 | 2024 | Teriparatide |
| Bayer Healthcare Pharmaceuticals INC. | $18.61 | 2024 | |
| Medtronic, INC. | $18.32 | 2024 | Minimed 780g |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.